EQUITY Equity (Tables)
|
6 Months Ended |
Jun. 30, 2025 |
|---|
| Equity [Abstract] |
|
| Schedule of Accumulated Other Comprehensive Income (Loss) |
The following table presents changes in the components of AOCI, net of taxes, for the six months ended June 30, 2025:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Flow Hedge |
|
Cumulative Foreign Currency Translation Adjustments |
|
Total |
|
(in thousands) |
| Balance at December 31, 2024 |
$ |
21,518 |
|
|
$ |
(356,630) |
|
|
$ |
(335,112) |
|
Other comprehensive income (loss) before reclassifications |
(1,253) |
|
|
190,815 |
|
|
189,562 |
|
| Amount reclassified from AOCI |
(6,896) |
|
|
— |
|
|
(6,896) |
|
| Net other comprehensive income (loss) |
(8,149) |
|
|
190,815 |
|
|
182,666 |
|
| Balance at June 30, 2025 |
$ |
13,369 |
|
|
$ |
(165,815) |
|
|
$ |
(152,446) |
|
|
| Schedule of Weighted Average Number of Shares |
The following table sets forth the computation of weighted average common shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
June 30, |
|
Six Months Ended
June 30, |
|
2025 |
|
2024 |
|
2025 |
|
2024 |
|
|
| Weighted average common shares—basic |
231,845,412 |
|
|
229,921,527 |
|
|
231,534,852 |
|
|
229,696,356 |
|
| Effect of dilutive securities: |
|
|
|
|
|
|
|
| Stock options and restricted stock |
2,572,016 |
|
|
2,076,808 |
|
|
2,930,952 |
|
|
2,327,958 |
|
| Convertible senior notes |
— |
|
|
13,004,660 |
|
|
192,804 |
|
|
— |
|
| Weighted average common shares—diluted |
234,417,428 |
|
|
245,002,995 |
|
|
234,658,608 |
|
|
232,024,314 |
|
|
| Potentially Dilutive Securities Excluded From Diluted Net Income (Loss) Per Common Share |
The following table shows securities excluded from the calculation of diluted net income per common share because such securities are anti-dilutive:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
June 30, |
|
Six Months Ended
June 30, |
|
2025 |
|
2024 |
|
2025 |
|
2024 |
| Options to purchase shares of common stock |
— |
|
|
3,750 |
|
|
— |
|
|
3,750 |
|
| Restricted stock and deferred stock—unvested |
1,188,300 |
|
|
2,464,785 |
|
|
1,188,300 |
|
|
2,743,310 |
|
|
|
|
|
|
|
|
|
| Conversion shares related to the convertible senior notes |
14,946,450 |
|
|
— |
|
|
14,946,450 |
|
|
13,004,660 |
|
| Number of anti-dilutive potentially issuable shares excluded from diluted common shares outstanding |
16,134,750 |
|
|
2,468,535 |
|
|
16,134,750 |
|
|
15,751,720 |
|
|